Evidence map›Paper›PMID 33097982›Full record

ReviewCurrent hypertension reports2020

Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias.

Arun Ganesh, Yawar J Qadri, Richard L Boortz-Marx, Sana M Al-Khatib, David H Harpole, Jason N Katz, Jason I Koontz, Joseph P Mathew, Neil D Ray, Albert Y Sun and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Current hypertension reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Arun GaneshDuke Anesthesiology, Duke University, Durham, NC, USA.
Yawar J QadriEmory Anesthesiology, Emory University, Atlanta, GA, USA.
Richard L Boortz-MarxDuke Anesthesiology, Duke University, Durham, NC, USA.
Sana M Al-KhatibDuke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.
David H HarpoleCardiothoracic Surgery, Duke University Medical Center, Durham, NC, USA.
Jason N KatzDuke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.
Jason I KoontzDuke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.
Joseph P MathewDuke Anesthesiology, Duke University, Durham, NC, USA.
Neil D RayDuke Anesthesiology, Duke University, Durham, NC, USA.
Albert Y SunDuke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.
Betty C TongCardiothoracic Surgery, Duke University Medical Center, Durham, NC, USA.
Luis UlloaDuke Anesthesiology, Duke University, Durham, NC, USA.
Jonathan P PicciniDuke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.
Marat FudimDuke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA. marat.fudim@dm.duke.edu.ORCID 0000-0002-8671-7007
Duke Medical Center · USDuke University · USClinical Research Institute · USEmory University · US

Funding

Dopaminergic regulation of the immune systemR01GM114180 · NIGMS · RBHS-NEW JERSEY MEDICAL SCHOOL · PI ULLOA, LUIS · 2015 to 2018
$1.2M
NIGMS NIH HHS R01 GM114180
6 · The paper itself

Abstract

purpose of reviewTo highlight the indications, procedural considerations, and data supporting the use of stellate ganglion blockade (SGB) for management of refractory ventricular arrhythmias. RECENT

findingsIn patients with refractory ventricular arrhythmias, unilateral or bilateral SGB can reduce arrhythmia burden and defibrillation events for 24-72 h, allowing time for use of other therapies like catheter ablation, surgical sympathectomy, or heart transplantation. The efficacy of SGB appears to be consistent despite the type (monomorphic vs polymorphic) or etiology (ischemic vs non-ischemic cardiomyopathy) of the ventricular arrhythmia. Ultrasound-guided SGB is safe with low risk for complications, even when performed on anticoagulation. SGB is effective and safe and could be considered for patients with refractory ventricular arrhythmias.

Indexed as

Autonomic Nerve BlockHypertensionTachycardia, VentricularArrhythmias, CardiacHumansStellate GanglionStellate ganglion blockVentricular arrhythmiaVentricular fibrillationVentricular tachycardia

Identifiers

PMID33097982
PMCPMC7646199
OpenAlexW3093741280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.